Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. Oncimmune LLC is a wholly-owned subsidiary of Oncimmune LTD based in Nottingham, England. The company is committed to advancing early cancer detection through proprietary autoantibody assay technologies based on biological technology initially identified by John Robertson, M.D., professor of surgery at Nottingham University, England, and chief scientific officer of Oncimmune LTD. Ongoing research and development is conducted by Oncimmune under the direction of Dr. Robertson. The company’s mission is to develop early cancer detection tests to identify more than 90 percent of solid-tumor cancers, which make up 70 percent of all cancers including lung, breast, colorectal, prostate, stomach, pancreatic and ovarian. As a lab service, Oncimmune’s metro Kansas City laboratory is CLIA-certified under the Clinical Laboratory Improvements Amendment of 1988. Oncimmune LTD owns a portfolio of patents including No. 7,402,403 and No. 7,205,117.

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

A cloud search tool that lets you search across all your apps (like Slack, JIRA, Trello, Google Drive, GitHub, email...) in one shot, saving you time every day. CTX takes 2 minutes to set up and then keeps in sync with the changes you make to your files, tickets, issues, messages and emails, so you always have up-to-date, relevant results at your fingertips.

Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

Conexio-Genomics is a privately operating life sciences company located in Fremantle, Western Australia.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.

Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, providing end-to-end technology transfer services. MOR helps inventors translate new ideas in the medical, pharmaceutical, diagnostics, medical IT, and biotechnology areas into products and solutions that benefit healthcare providers and patients.

Beijing Kelidandi Biomedical Technology Co., Ltd., established on 2019-07-09, Business scope includes biological,the medical,food,medical artificial intelligence,Technology Development of Electronic Information System,Technology Promotion,Technical Services,technology transfer,technical consulting;Sales of medical devicesIkind,medical instrumentsIIkind,Chemical Products(Free of Hazardous Chemicals),biological reagent(Does not contain drugs);cloud computing center(onlyPUEvalue1.4the following);Agricultural Science Research and Experimental Development;Technology Import and Export,Import and export;Professional contractors;Organize cultural and artistic exchange activities(without show);Solid waste pollution control;retail medicine;wholesale medicine;sell food;wholesale,Retail Class III Medical Devices;Production of the second class,Class III medical devices.(Enterprises independently choose operating projects according to law,Carry out business activities;retail medicine,wholesale medicine,sell food,wholesale,Retail Class III Medical Devices,Production of the second class,Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.).

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other. The company was founded in September 1971 and is headquartered in Irvine, CA.

D&P Biotech, Inc. is engaged in research and development of molecular diagnostics. The company was founded on March 3, 2006 and is headquartered in Seoul, South Korea.

SolGent Co., Ltd. provides solutions for molecular biology, molecular diagnostics and genetics. Its business areas are Molecular Diagnosis, Molecular Biology and Genetic Analysis Service. The firm's Molecular Diagnosis business develops pathogen detection and human genotype kit and microbial screening, Molecular Biology research offers amplification, cloning, and biological reagents and the Genetic Analysis Service provides sequencing, genotyping, DNA fingerprinting, and microorganism identification service. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia).

New Target (Shanghai) Molecular Medical Technology Co., Ltd., established on 2005-09-27, Business scope includes molecular medical technology,Technology development in the field of data analysis software,technical consulting,technology transfer,Technical Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Shanghai Eryun Information Technology Co., Ltd., established on 2015-02-02, The scope of business includes engaging in information technology,gene technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,business inquiries,Business Management Consulting,computer,Software and Auxiliary Equipment,Laboratory Instruments and Consumables,Biological product,chemicals(Removal of hazardous chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.